| C08CA05 |
Nifedipine |
Cordaflex |
Prolonged release tablet |
20 |
mg |
60 |
EGIS Pharmaceuticals PLC, Унгария |
30 |
mg |
- |
4.86 |
0.1215 |
4.86 |
50% |
2.43 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
НСР-3551/16.05.2014; КП-29/05.03.2015 и НСР-1520/25.10.2013; НСР-13080/29.06.2017 |
02.08.2017 |
08.09.2012 |
|
Активен |
3646 |
| C08CA05 |
Nifedipine |
Cordaflex |
Prolonged release tablet |
20 |
mg |
30 |
EGIS Pharmaceuticals PLC, Унгария |
30 |
mg |
- |
3.74 |
0.1215 |
2.43 |
50% |
1.21 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
|
02.08.2017 |
08.09.2012 |
|
Активен |
370 |
| C08CA05 |
Nifedipine |
CORINFAR |
Prolonged release tablet |
20 |
mg |
30 |
Екофарм Груп АД, България |
30 |
mg |
- |
3.65 |
0.1215 |
2.43 |
50% |
1.21 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
КЦPP-813/15.06.2012 г.НСР-3347/24.04.2014; НСР-3279/24.04.2014; НСР-16469/17.08.2018; НСР-21325/23.04.2020 Предварително изпълнение |
02.05.2020 |
08.09.2012 |
|
Активен |
2755 |
| C08CA05 |
Nifedipine |
KORINCARE |
Prolonged release tablet |
20 |
mg |
20 |
Чайкафарма Висококачествените лекарства АД, България |
30 |
mg |
- |
2.87 |
0.1215 |
1.62 |
50% |
0.81 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
НСР-2411/21.01.2014; НСР-18195/19.03.2019 |
02.05.2019 |
08.09.2012 |
|
Активен |
2528 |
| C08CA05 |
Nifedipine |
NIFEDIPIN ACTAVIS |
Film coated tablet |
10 |
mg |
50 |
Актавис EАД, България |
30 |
mg |
- |
2.89 |
0.1215 |
2.03 |
50% |
1.01 |
за краткосрочно лечение |
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
НСР-14915/25.01.2018 |
02.03.2018 |
08.09.2012 |
|
Заличен |
234 |
| C08CA05 |
Nifedipine 100% |
C08CA05 Nifedipine 100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C08CA05 |
Nifedipine |
Cordaflex |
Prolonged release tablet |
20 |
mg |
60 |
EGIS Pharmaceuticals PLC, Унгария |
30 |
mg |
4.09 |
- |
0.10225 |
4.09 |
100% |
4.09 |
|
I10 |
HCP-8810/13.04.2016; НСР-13080/29.06.2017. |
02.08.2019 |
08.09.2012 |
|
Активен |
3646 |
| C08CA05 |
Nifedipine |
Cordaflex |
Prolonged release tablet |
20 |
mg |
30 |
EGIS Pharmaceuticals PLC, Унгария |
30 |
mg |
3.16 |
- |
0.10225 |
2.05 |
100% |
2.05 |
|
I10 |
HCP-8810/13.04.2016. |
02.08.2019 |
08.09.2012 |
|
Активен |
370 |
| C08CA05 |
Nifedipine |
CORINFAR |
Prolonged release tablet |
20 |
mg |
30 |
Екофарм Груп АД, България |
30 |
mg |
3.07 |
- |
0.10225 |
2.05 |
100% |
2.05 |
|
I10 |
HCP-8813/13.04.2016; НСР-16469/17.08.2018; НСР-21325/23.04.2020 Предварително изпълнение |
02.05.2020 |
08.09.2012 |
|
Активен |
2755 |
| C08CA05 |
Nifedipine |
KORINCARE |
Prolonged release tablet |
20 |
mg |
20 |
Чайкафарма Висококачествените лекарства АД, България |
30 |
mg |
2.41 |
- |
0.10225 |
1.36 |
100% |
1.36 |
|
I10 |
HCP-8812/13.04.2016; НСР-18195/19.03.2019. |
02.08.2019 |
08.09.2012 |
|
Активен |
2528 |
| C08CA06 |
Nimodipine |
C08CA06 Nimodipine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C08CA06 |
Nimodipine |
NIMOTOP S |
Film coated tablet |
30 |
mg |
100 |
Bayer AG, Германия |
300 |
mg |
- |
31.98 |
3.198 |
31.98 |
50% |
15.99 |
|
I69.0 |
НСР-210/18.06.2013; НСР-2929/07.03.2014; НСР-8324/26.02.2016 |
02.04.2016 |
08.09.2012 |
|
Активен |
1889 |
| C08CA08 |
Nitrendipine |
C08CA08 Nitrendipine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C08CA08 |
Nitrendipine |
NITRENDIPIN ACTAVIS |
Tablet |
20 |
mg |
30 |
Актавис EАД, България |
20 |
mg |
- |
3.72 |
0.124 |
3.72 |
25% |
0.93 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-11354/30.12.2016 |
02.02.2017 |
08.09.2012 |
|
Заличен |
93 |
| C08CA09 |
Lacidipine |
C08CA09 Lacidipine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C08CA09 |
Lacidipine |
Lacipil |
Film coated tablet |
4 |
mg |
28 |
GlaxoSmithKline (Ireland) Limited, Ирландия |
4 |
mg |
- |
8.1 |
0.28929 |
8.1 |
50% |
4.05 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 184/ 15.08.2011; № 255/ 04.11.2011; НСР-2125/14.12.2013; НСР-18246/22.03.2019 |
02.05.2019 |
08.09.2012 |
|
Активен |
2388 |
| C08CA09 |
Lacidipine 100% |
C08CA09 Lacidipine 100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C08CA09 |
Lacidipine |
Lacipil |
Film coated tablet |
4 |
mg |
28 |
GlaxoSmithKline (Ireland) Limited, Ирландия |
4 |
mg |
6.83 |
- |
0.24393 |
6.83 |
100% |
6.83 |
|
I10 |
HCP-8815/13.04.2016; НСР-18246/22.03.2019. |
02.08.2019 |
08.09.2012 |
|
Активен |
2388 |
| C08CA13 |
Lercanidipine hydrochloride |
C08CA13 Lercanidipine hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C08CA13 |
Lercanidipine |
Areta |
Film coated tablet |
20 |
mg |
14 |
Stada Arzneimittel AG, Германия |
10 |
mg |
- |
8.94 |
0.20067 |
5.62 |
50% |
2.81 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-4150/23.07.2014; НСР-6866/30.07.2015. |
02.09.2015 |
|
|
Заличен |
3041 |
| C08CA13 |
Lercanidipine |
Areta |
Film coated tablet |
10 |
mg |
14 |
Stada Arzneimittel AG, Германия |
10 |
mg |
- |
5.95 |
0.20067 |
2.81 |
50% |
1.4 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-4150/23.07.2014; НСР-5263/10.12.2014 |
02.01.2015 |
|
|
Заличен |
3040 |
| C08CA13 |
Lercanidipine |
ARETA |
Film coated tablet |
20 |
mg |
30 |
Stada Arzneimittel AG, Германия |
10 |
mg |
- |
12.04 |
0.188 |
11.28 |
50% |
5.64 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 106/ 23.09.2010; НСР-1104/04.09.2013; НСР-3394/29.04.2014.; |
02.08.2018 |
08.09.2012 |
|
Активен |
2781 |
| C08CA13 |
Lercanidipine |
ARETA |
Film coated tablet |
10 |
mg |
30 |
Stada Arzneimittel AG, Германия |
10 |
mg |
- |
9.58 |
0.188 |
5.64 |
50% |
2.82 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 101/ 20.09.2010; КЦРР-2069/24.01.2013 г; НСР-2133/14.12.2013.; |
02.08.2018 |
08.09.2012 |
|
Активен |
2364 |
| C08CA13 |
Lercanidipine |
Caniler |
Film coated tablet |
20 |
mg |
30 |
Sandoz d.d., Словения |
10 |
mg |
- |
11.81 |
0.188 |
11.28 |
50% |
5.64 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-7652/01.12.2015.; КП-133/06.11.2017 и НСР-13163/17.07.2017; АССГ № 531/29.01.2018 и ВАС № 7806/12.06.2018 |
02.08.2018 |
|
|
Активен |
4137 |
| C08CA13 |
Lercanidipine |
Caniler |
Film coated tablet |
10 |
mg |
30 |
Sandoz d.d., Словения |
10 |
mg |
- |
5.64 |
0.188 |
5.64 |
50% |
2.82 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-7652/01.12.2015.; КП-98/25.10.2017 и НСР-13162/17.07.2017 |
02.08.2018 |
|
|
Активен |
4136 |